Clinical outcomes and associated factors in the treatment of peri‐implant mucositis, combining mechanical debridement and prosthesis modification: A 30‐month follow‐up prospective case series

Aim To evaluate the clinical outcome and the associated factors of a treatment protocol for peri‐implant mucositis. Materials and Methods Patients were evaluated 30 months after a treatment protocol including professional mechanical debridement and modification of the prosthesis contours to improve...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical periodontology 2022-12, Vol.49 (12), p.1357-1365
Main Authors: Tapia, Beatriz, Bonnin, Maria, Valles, Cristina, Mozas, Carla, Herrera, David, Sanz, Mariano, Nart, José
Format: Article
Language:English
Subjects:
Biofilms
Bleeding
Debridement
dental implant
Dental implants
Dental Implants - adverse effects
dental prosthesis
Dental prosthetics
Follow-Up Studies
Humans
implant‐supported
Inflammation
Mucosa
Mucositis
Mucositis - etiology
Mucositis - therapy
non‐surgical treatment
Original
Palliative care
Patients
Peri-Implantitis - therapy
peri‐implant mucositis
Plaque index
Prostheses
Stomatitis - etiology
Stomatitis - therapy
Therapy
Transplants & implants
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim To evaluate the clinical outcome and the associated factors of a treatment protocol for peri‐implant mucositis. Materials and Methods Patients were evaluated 30 months after a treatment protocol including professional mechanical debridement and modification of the prosthesis contours to improve access for biofilm control. Clinical performance was assessed by means of probing with an electronic pressure‐calibrated periodontal probe. The possible impact of implant‐ and patient‐level factors on the changes in peri‐implant mucosal inflammation measured with the modified bleeding index (mBI) was evaluated. Results Twenty patients and 61 implants were included in the analysis. At the final visit, 50% of the patients presented bleeding on probing, with a mean mBI of 0.22 (SD 0.27). The adjusted linear regression model showed a significant association between patient's compliance with supportive care visits (p = .006) and mucosal inflammation. Similarly, at the implant level, modified plaque index (p 
ISSN:0303-6979
1600-051X
DOI:10.1111/jcpe.13711